194 related articles for article (PubMed ID: 10068666)
1. Cytoplasmic domains of the leukemia inhibitory factor receptor required for STAT3 activation, differentiation, and growth arrest of myeloid leukemic cells.
Tomida M; Heike T; Yokota T
Blood; 1999 Mar; 93(6):1934-41. PubMed ID: 10068666
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional studies on the leukemia inhibitory factor receptor (LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cells.
Tomida M
Leuk Lymphoma; 2000 May; 37(5-6):517-25. PubMed ID: 11042511
[TBL] [Abstract][Full Text] [Related]
3. A selective switch-on system for self-renewal of embryonic stem cells using chimeric cytokine receptors.
Nakamura T; Arai T; Takagi M; Sawada T; Matsuda T; Yokota T; Heike T
Biochem Biophys Res Commun; 1998 Jul; 248(1):22-7. PubMed ID: 9675079
[TBL] [Abstract][Full Text] [Related]
4. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
5. Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor receptor and gp130 cooperate in signal transduction in hepatic and neuronal cells.
Baumann H; Symes AJ; Comeau MR; Morella KK; Wang Y; Friend D; Ziegler SF; Fink JS; Gearing DP
Mol Cell Biol; 1994 Jan; 14(1):138-46. PubMed ID: 8264582
[TBL] [Abstract][Full Text] [Related]
6. The carboxyl-terminal domains of gp130-related cytokine receptors are necessary for suppressing embryonic stem cell differentiation. Involvement of STAT3.
Ernst M; Novak U; Nicholson SE; Layton JE; Dunn AR
J Biol Chem; 1999 Apr; 274(14):9729-37. PubMed ID: 10092661
[TBL] [Abstract][Full Text] [Related]
7. Distinct roles for leukemia inhibitory factor receptor alpha-chain and gp130 in cell type-specific signal transduction.
Starr R; Novak U; Willson TA; Inglese M; Murphy V; Alexander WS; Metcalf D; Nicola NA; Hilton DJ; Ernst M
J Biol Chem; 1997 Aug; 272(32):19982-6. PubMed ID: 9242667
[TBL] [Abstract][Full Text] [Related]
8. The box-1 region of the leukemia inhibitory factor receptor alpha-chain cytoplasmic domain is sufficient for hemopoietic cell proliferation and differentiation.
Zhang Y; Willson T; Metcalf D; Cary D; Hilton DJ; Clark R; Nicola NA
J Biol Chem; 1998 Dec; 273(51):34370-83. PubMed ID: 9852103
[TBL] [Abstract][Full Text] [Related]
9. Chimeric cytokine receptor can transduce expansion signals in interleukin 6 receptor alpha (IL-6Ralpha)-, IL-11Ralpha-, and gp130-low to -negative primitive hematopoietic progenitors.
Takagi M; Nakamura T; Sawada T; Kaneko A; Nozaki-Ukai M; Nakahata T; Yokota T; Heike T
Mol Biol Cell; 1999 Nov; 10(11):3633-42. PubMed ID: 10564261
[TBL] [Abstract][Full Text] [Related]
10. [Signal of the cytoplasmic regions of leukemia inhibitory factor receptor (LIFR) alpha-subunit and gp130 involves Stat3 activation in leukemic U937 cells].
Liu H; Tang S; Liu S
Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):621-3. PubMed ID: 11721361
[TBL] [Abstract][Full Text] [Related]
11. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6.
Kuropatwinski KK; De Imus C; Gearing D; Baumann H; Mosley B
J Biol Chem; 1997 Jun; 272(24):15135-44. PubMed ID: 9182534
[TBL] [Abstract][Full Text] [Related]
12. Induction of differentiation of WEHI-3B D+ leukemic cells transfected with differentiation-stimulating factor/leukemia inhibitory factor receptor cDNA.
Tomida M
Blood; 1995 Jan; 85(1):217-21. PubMed ID: 7528568
[TBL] [Abstract][Full Text] [Related]
13. Box 3-independent signaling mechanisms are involved in leukemia inhibitory factor receptor alpha- and gp130-mediated stimulation of mitogen-activated protein kinase. Evidence for participation of multiple signaling pathways which converge at Ras.
Schiemann WP; Bartoe JL; Nathanson NM
J Biol Chem; 1997 Jun; 272(26):16631-6. PubMed ID: 9195977
[TBL] [Abstract][Full Text] [Related]
14. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
Piekorz RP; Hocke GM
Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of signaling events mediated by the cytoplasmic domain of leukemia inhibitory factor receptor alpha subunit.
Liu H; Liu S; Tang S; Ji K; Wang F; Hu S
Mol Cell Biochem; 2004 Mar; 258(1-2):15-23. PubMed ID: 15030166
[TBL] [Abstract][Full Text] [Related]
16. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
[TBL] [Abstract][Full Text] [Related]
17. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
[TBL] [Abstract][Full Text] [Related]
18. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
[TBL] [Abstract][Full Text] [Related]
19. The unusual species cross-reactivity of the leukemia inhibitory factor receptor alpha-chain is determined primarily by the immunoglobulin-like domain.
Owczarek CM; Zhang Y; Layton MJ; Metcalf D; Roberts B; Nicola NA
J Biol Chem; 1997 Sep; 272(38):23976-85. PubMed ID: 9295349
[TBL] [Abstract][Full Text] [Related]
20. Leukemia inhibitory factor enhances mast cell growth in a mast cell/fibroblast co-culture system through stat3 signaling pathway of fibroblasts.
Hiragun T; Morita E; Mihara S; Tanaka T; Gyotoku E; Kameyoshi Y; Yamamoto S
FEBS Lett; 2000 Dec; 487(2):219-23. PubMed ID: 11150513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
